Delivery Order SPE2DX15D1104-SPE2DX23F3XP2
- Not listed
- This federal contract award is for the delivery of Lumigan 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,130.27 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 20, 2024, with a completion date of February 21, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award is for the delivery of Lumigan 0.01% eye drops, 5 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price of $2,401.44 and an ultimate completion date of January 10, 2022. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Lumigan 0.01% eye drops to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,747.98 and was awarded on January 20, 2022, with a completion date of January 21, 2022. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lumigan 0.01% eye drops. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $1,737.57. The award was made on September 21, 2021, with a completion date of September 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit organization registered in the System for Award Management...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,079.64 for the supply of Lumigan 0.01% eye drops. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 11, 2022. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lumigan 0.01% eye drops. The contract is a Delivery Order with a Firm Fixed Price of $2,344.06 and an ultimate completion date of August 19, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $1,457.37, was made to the prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.89 firm fixed-price delivery order is for the supply of Lumigan 0.01% eye drops, a specialty ophthalmic medication. The contract, which has a completion date of June 16, 2023, is not designated under any set-aside program. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $3,084.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lumigan 0.01% eye drops in 5ml vials. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
- This federal contract award is for the delivery of LUMIGAN 0.01% eye drops, 5ml, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,051.44 and a completion date of January 30, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an...
- SPE2DX15D1104Indefinite Delivery Contract
- SPE2DX15D1104-SPE2DX23F3XP2Delivery Order
This federal contract award is for the delivery of Lumigan 0.01% eye drops, 5 mL, to the Department of Defense (DoD) Medical Supply Chain (identified as the Defense Logistics Agency (DLA) Troop Support Medical). The contract, valued at $18,603.05, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 18, 2023, with a completion date of September 19, 2023. The contract is a firm-fixed-price delivery order and does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.6k | 9/18/23 |